Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report which finds that the global insulin market is expected to witness double-digit growth during 2007-2012.
Insulin Delivery Systems Market Analysis- (2007-2010), which is available at http://www.piribo.com/
The report analyses the global insulin market and various insulin delivery methods. It investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, needle-free injectors and inhalers.
It also takes into account pros and cons of each device and gives a detailed analysis on their future prospects. Analysts find that insulin syringes and pumps dominate the US market.
Authors of the report say that the growth in the insulin market is directly linked to the growing number of diabetics. It predicts that around 380 million people will suffer from diabetes by 2025, making this an attractive market for drug companies.
In addition, they say that most of the insulin available today, is available in injectable form through syringes, pens, pumps and needle-free devices.
The report evaluates past, current and future market trends. It analyses the major insulin delivery devices and outlines the scope of the major insulin delivery systems all over the world. It also analyses the various challenges and opportunities present in the industry.
The study provides an overview, key facts and financial information of prominent players in the global insulin delivery market like Eli Lilly & Company, Novo Nordisk A/S, Sanofi-Aventis, Becton Dickinson & Company and Medtronic Inc.
Insulin Delivery Systems Market Analysis- (2007-2010) is available in pdf format from Piribo. For more information, go to:
http://www.piribo.com/
Piribo product ID: RCS296
